These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 11507357)

  • 61. Interest of fecal calprotectine dosage in inflammatory bowel diseases, state of the art and perspectives.
    Chaabouni T; Manceau H; Peoc'h K
    Ann Biol Clin (Paris); 2016 Aug; 74(4):385-94. PubMed ID: 27492691
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Current status of ultrasound in gastroenterology--bowel and upper gastrointestinal tract--part 2].
    Nuernberg D; Ignee A; Dietrich CF
    Z Gastroenterol; 2008 Apr; 46(4):355-66. PubMed ID: 18393155
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Failure of gastroenterologists to apply intestinal ultrasound in inflammatory bowel disease in the Asia-Pacific: a need for action.
    Asthana AK; Friedman AB; Maconi G; Maaser C; Kucharzik T; Watanabe M; Gibson PR
    J Gastroenterol Hepatol; 2015 Mar; 30(3):446-52. PubMed ID: 25529767
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A simple score for the identification of patients at high risk of organic diseases of the colon in the family doctor consulting room. The Local IBS Study Group.
    Bellentani S; Baldoni P; Petrella S; Tata C; Armocida C; Marchegiano P; Saccoccio G; Manenti F
    Fam Pract; 1990 Dec; 7(4):307-12. PubMed ID: 2289644
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Ultrasonography in inflammatory bowel diseases--preliminary results].
    Eriksen R; Qvigstad T
    Tidsskr Nor Laegeforen; 2002 Nov; 122(27):2594-7. PubMed ID: 12523185
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Usefulness of Contrast-Enhanced Ultrasound in Differentiating Inflammatory Bowel Disease From Colon Cancer.
    Zhang F; Miao LY; Ge HY; Tan S; Li ZQ; Zhao B
    Ultrasound Med Biol; 2018 Jan; 44(1):124-133. PubMed ID: 29126753
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Is-it possible to distinguish irritable bowel syndrome with constipation from functional constipation?
    Bouchoucha M; Devroede G; Bon C; Bejou B; Mary F; Benamouzig R
    Tech Coloproctol; 2017 Feb; 21(2):125-132. PubMed ID: 28066860
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Kruis scoring system and Manning's criteria in diagnosis of irritable bowel syndrome: is it better to use combined?
    Doğan UB; Unal S
    Acta Gastroenterol Belg; 1996; 59(4):225-8. PubMed ID: 9085621
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Evaluation of Manning's criteria in the diagnosis of irritable bowel syndrome.
    Rao KP; Gupta S; Jain AK; Agrawal AK; Gupta JP
    J Assoc Physicians India; 1993 Jun; 41(6):357-8, 363. PubMed ID: 8005973
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Irritable bowel syndrome with constipation and functional constipation in adults: Treatment (Part 2 of 2)].
    Mearin F; Ciriza C; Mínguez M; Rey E; Mascort JJ; Peña E; Cañones P; Júdez J;
    Semergen; 2017 Mar; 43(2):123-140. PubMed ID: 28189496
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prevalence and correlates of irritable bowel symptoms in a New Zealand birth cohort.
    Barbezat G; Poulton R; Milne B; Howell S; Fawcett JP; Talley N
    N Z Med J; 2002 Oct; 115(1164):U220. PubMed ID: 12552296
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome.
    Pimentel M; Chow EJ; Lin HC
    Am J Gastroenterol; 2000 Dec; 95(12):3503-6. PubMed ID: 11151884
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Ultrasonographic findings correspond to clinical, endoscopic, and histologic findings in inflammatory bowel disease and other enterocolitides.
    Haber HP; Busch A; Ziebach R; Dette S; Ruck P; Stern M
    J Ultrasound Med; 2002 Apr; 21(4):375-82. PubMed ID: 11934094
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Calprotectin: a fecal marker for diagnosis and follow-up in patients with chronic inflammatory bowel disease].
    van den Bergh FA; Kolkman JJ; Russel MG; Vlaskamp RT; Vermes I
    Ned Tijdschr Geneeskd; 2003 Nov; 147(48):2360-5. PubMed ID: 14677476
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prospective evaluation of faecal neutrophil-derived proteins in identifying intestinal inflammation: combination of parameters does not improve diagnostic accuracy of calprotectin.
    Schröder O; Naumann M; Shastri Y; Povse N; Stein J
    Aliment Pharmacol Ther; 2007 Oct; 26(7):1035-42. PubMed ID: 17877510
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Positron emission tomography in the investigation of pediatric inflammatory bowel disease.
    Lemberg DA; Issenman RM; Cawdron R; Green T; Mernagh J; Skehan SJ; Nahmias C; Jacobson K
    Inflamm Bowel Dis; 2005 Aug; 11(8):733-8. PubMed ID: 16043988
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Role of CT colonography in inflammatory bowel disease.
    Regge D; Neri E; Turini F; Chiara G
    Eur J Radiol; 2009 Mar; 69(3):404-8. PubMed ID: 19167180
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Abdominal pain - differential diagnoses and diagnostic strategies in patients with chronic symptoms].
    Güller U; Macpherson AJ
    Ther Umsch; 2011 Aug; 68(8):459-62. PubMed ID: 21796598
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Fecal dimeric M2-pyruvate kinase (tumor M2-PK) in the differential diagnosis of functional and organic bowel disorders.
    Jeffery J; Lewis SJ; Ayling RM
    Inflamm Bowel Dis; 2009 Nov; 15(11):1630-4. PubMed ID: 19462434
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Impact of intestinal ultrasound on the management of patients with inflammatory bowel disease: how to apply scientific evidence to clinical practice.
    Fraquelli M; Castiglione F; Calabrese E; Maconi G
    Dig Liver Dis; 2020 Jan; 52(1):9-18. PubMed ID: 31732443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.